NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Adverse Outcomes and Mortality in Liver Transplant
Adverse Outcomes and Mortality in Liver Transplant
RecruitingNA
Sponsor: Mayo Clinic
Conditions: End Stage Liver DIsease, Sarcopenia, Sarcopenic Obesity, Cirrhosis
Interventions: MAsS
Countries: United States
Prospective natural history pilot study to explore the link between muscle composition using an MRI-based Muscle Assessment Score (MAsS) and adverse outcomes in liver transplant candidates.
Eligibility overview
Sex: ALL
Age: 18 Years to —
Healthy volunteers: No
Study type: INTERVENTIONAL
Eligibility criteria
Inclusion Criteria: 1. All patients with end-stage liver disease undergoing evaluation for liver transplantation 2. Patient clinically indicated for MRI during transplant candidacy evaluation 3. Adult Exclusion Criteria: 1\. Contra indication to MRI
Locations (1)
- Phoenix, Arizona, United States